NIH GRANT ACCOUNTING 

The National Institutes of Health (NIH), operating under the Department of Health and Human Services (HHS), is one of the largest federal funding agencies supporting biomedical research, life sciences innovation, and healthcare technology development. NIH provides funding through a variety of grant mechanisms including research grants, cooperative agreements, and the SBIR/STTR programs. Among these, SBIR and STTR awards represent some of the most common funding vehicles for small businesses seeking to commercialize innovative research.

Though NIH grants are assistance awards rather than procurement contracts, they still require recipients to maintain financial management systems capable of demonstrating that costs are allowable, allocable, and reasonable under Uniform Guidance (2 CFR 200). Beyond Uniform Guidance requirements, many NIH SBIR/STTR awards incorporate cost principles derived from FAR Part 31 through agency policy and award terms (particularly for for-profit entities). As a result, many grantees with certain grant types— like an NIH Ph II—should implement accounting structures similar to those used for cost-reimbursable federal contracts, including proper segregation of direct and indirect costs, compliant timekeeping systems, labor distribution tracking, and clear documentation supporting project expenses (which is why installing a DCAA compliant accounting system for federal grantees is the standard operating procedure for govcon accounting firms like ReliAscent®). 

From a practical standpoint, NIH typically focuses on a few fundamental accounting areas when evaluating compliance:

• • Are labor charges supported by time records

  • Are indirect costs applied consistently

  • Do your expenses align with the approved budget, and

  • Are your internal financial controls adequate to safeguard federal funds

     

Establishing sound accounting practices early helps NIH awardees avoid compliance issues, prepares them for potential audits or financial reviews, and positions them for future federal funding opportunities.

NIH SBIR/STTR ACCOUNTING

The NIH SBIR/STTR programs are designed to help small businesses move technologies from early-stage research toward commercialization. Phase I awards typically support feasibility studies and proof-of-concept work, while Phase II awards focus on continued R&D, prototype development, and commercialization readiness. Phase I awards are typically in the range of $300,000–$400,000 depending on the institute and solicitation, while Phase II awards usually range from $1 million to $2 million or more depending on the project scope and NIH institute.

From an accounting perspective, NIH expects SBIR/STTR awardees to maintain sufficient financial records to demonstrate that grant funds were spent appropriately and in accordance with the approved budget. This typically includes tracking direct project costs, maintaining support for labor charges, properly managing subcontract costs, and ensuring indirect costs are applied according to the approved rate structure. While the level of scrutiny increases significantly between Phase I and Phase II, companies that implement good accounting habits early typically experience a much smoother transition into the more rigorous Phase II compliance environment.

ESTABLISHING & NEGOTIATING AN INDIRECT RATE (F&A RATE) FOR AN NIH PROPOSAL

Indirect cost rates (often referred to as Facilities & Administrative or F&A rates) are one of the most important financial components of an NIH SBIR/STTR proposal. Companies have the option of using the 10% de minimis indirect rate allowed under Uniform Guidance if they have never established a negotiated rate, or they may propose a higher rate if they can justify it using a defensible cost allocation methodology.

While the de minimis rate may appear attractive due to its simplicity, many small businesses find that their actual indirect costs significantly exceed 10%. Companies that fail to properly calculate their rates may unintentionally leave substantial funding on the table. At ReliAscent®, our experts help companies develop indirect rate structures during the proposal stage to ensure budgets reflect the true cost of operating the business while remaining compliant with federal cost principles, for an affordable rate. We also assist companies with preparing rate support documentation and navigating rate negotiations when required after award.